FORM 6-K
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Special Report of Foreign Issuer
Pursuant to Rule 13a-16 or 15d-16 of
the Securities and Exchange Act of 1934
For the date of November 19, 2002
Centerpulse Ltd.
(Translation of registrant's name into English)
Andreasstrasse 15
CH-8050 Zurich
Switzerland
(Address of principal executive office)
(Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.)
Form 20-F X Form 40-F
(Indicate by check mark whether the registrant by furnishing the information contained in this form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.)
Yes No X
(If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- .)
Centerpulse Ltd. is filing this Report on Form 6-K to furnish the media release announcing that it has entered into a definitive agreement to sell IntraTherapeutics Inc., which media release is attached hereto as Exhibit 99.1.
Centerpulse Ltd. hereby incorporates this Report on Form 6-K by reference into the Registration Statements on Form S-8, No. 33-8300, No. 333-76280 and No. 333-85388.
| 99.1 | Media Release, dated September 3, 2002, announcing that Centerpulse Ltd. has entered into a definitive agreement to sell IntraTherapeutics Inc. |
2
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorised.
| CENTERPULSE LTD. | |||
By: |
/s/ DAVID S. WISE David S. Wise Authorized Representative |
Date: November 19, 2002
3
| Exhibit |
Description |
|
|---|---|---|
| 99.1 | Media Release, dated September 3, 2002, announcing that Centerpulse Ltd. has entered into a definitive agreement to sell IntraTherapeutics Inc. |
4